LINC01840

Across TCGA pan-cancer cohorts, LINC01840 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated LINC01840 data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher LINC01840 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC01840 expression acts as an unfavorable survival marker, although some lineages such as LGG and LAML show a favorable association.

LGG, KIRP, and MESO are the cancer types where LINC01840 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Median	All	0.495	0.303	<.001	54	view →
KIRP	OS	Tertile	II,III,IV	0.122	0.715	<.001	36	view →
MESO	DFS	Tertile	III,IV	0.237	0.399	.021	27	view →
LAML	DFS	Tertile	All	0.518	0.316	.026	24	view →
LUAD	DFS	Tertile	II,III,IV	0.568	0.202	.014	15	view →
LIHC	OS	Tertile	All	0.493	0.717	.035	12	view →
THYM	DFS	Tertile	All	0.705	0.937	.013	9	view →
READ	DFS	Median	All	0.676	0.401	.020	5	view →
COAD	OS	Median	IV	0.308	0.659	.028	2	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

LINC01840–LGG (DFS)

Open the LGG breakdown →